SCHEMBL5162690

SCHEMBL5162690

CCc1cc(NC(=N)N)ccc1S(N)(=O)=O

nearest known ligand 0.41

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 18/20 0.41
▸ CA2 P00918 18/20 0.41
▸ CA9 Q16790 8/20 0.39
▸ CA12 O43570 7/20 0.39
▸ F10 P00742 1/20 0.37
▸ CA7 P43166 3/20 0.36
▸ CA14 Q9ULX7 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5161486 0.82 P2RX4 (0.40) CA1CA2CA9CA12F10
SCHEMBL5722111 0.81 KMT2A (0.56) CA1CA2CA9CA12CA7
SCHEMBL16861415 0.78 CA12 (0.56) CA1CA2CA9CA12CA7
SCHEMBL7737219 0.77 CA1 (0.46) CA1CA2CA9CA12
SCHEMBL8741155 0.76 TSHR (0.43) —
SCHEMBL11427182 0.76 CNR1 (0.42) CA1CA2CA9CA12CA7
SCHEMBL13785813 0.75 HSD17B10 (0.37) —
SCHEMBL10955222 0.74 GABRP (0.41) F10
SCHEMBL4619724 0.73 CA1 (0.35) CA1CA2CA9CA12CA7
SCHEMBL29839131 0.72 LMNA (0.45) CA1CA2CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756098-A2 2-SUBSTITUTED-4-HETEROARYL-PYRIMIDINES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Cyclacel Limited (GB) 2007-02-28 — — EP disclosed
WO-2005116025-A2 2-SUBSTITUTED-4-HETEROARYL-PYRIMIDINES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISORDERS CYCLACEL LIMITED (GB) 2005-12-08 — — WO disclosed
Send feedback